Alternative therapies and management of dementia in Alzheimer’s disease
Alternative therapies and management of dementia in Alzheimer’s disease

Summary/Abstract: Neurocognitive disorders are defined by an "significant cognitive impairment in one or moreareas: complex attention, executive function, learning and memory, language, perceptualmotor ability and social cognition. These dysfunctions represent a decline from a previouslevel of functioning, so dementia. does not refer to low or reduced intellectual functioning, ormental retardation, which are developmental and static disorders. "(1)Dementia of the Alzheimer's type is the most common nosological form of dementia,characterized by memory loss and other cognitive skills severe enough to interfere with dailylife. Dementia of the Alzheimer's type has a prevalence of 60-80% of dementia cases. (2)The factors that differentiate the dementia subtypes are: “evolution over time, the specificareas affected and the associated symptoms” (5)The therapeutic strategies are based on the increase of the cholinergic transmission and onthe modeling of the glutamatergic transmission, validated etiopathogenic hypotheses indementia Alzheimer's focus on acetylcholine transmission deficiency and NMDA receptorhyperactivity. (19)Patients diagnosed with a neurocognitive disorder such as dementia of theAlzheimer's type, represent a special group, with special needs, in which the concept ofquality of life differs from that used for patients diagnosed with conditions that are certainlyless disabling.A series of prospective cohort studies have suggested that in addition to anti - dementiapsychotropic therapy, regular physical activity associated with standardized herbal oily maceration such as garlic (Allium sativum), hawthorn (Crataegus oxyacantha - linne) andwhite mistletoe (Viscum album) may have a real effect on risk factors (diabetes, HTA,cerebrovascular disorders, X-metabolic syndrome).This paper proposes an analysis of both current psychotropic therapy, risk factors and theimpact of non-pharmacological treatment on the quality of life of people affected by thispathology.

• Details
• Contents